M1 Kliniken AG (ETR:M12)
19.00
0.00 (0.00%)
May 29, 2026, 5:35 PM CET
M1 Kliniken AG Employees
M1 Kliniken AG had 199 employees as of December 31, 2024. The number of employees decreased by 20 or -9.13% compared to the previous year.
Employees
199
Change (1Y)
-20
Growth (1Y)
-9.13%
Revenue / Employee
€1,301,068
Profits / Employee
€79,044
Market Cap
352.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 199 | -20 | -9.13% |
| Dec 31, 2023 | 219 | -147 | -40.16% |
| Dec 31, 2022 | 366 | 16 | 4.57% |
| Dec 31, 2021 | 350 | -78 | -18.22% |
| Dec 31, 2020 | 428 | 192 | 81.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,184 |
| MEDICLIN Aktiengesellschaft | 7,416 |
| Redcare Pharmacy NV | 2,163 |
| Stratec SE | 1,343 |
M1 Kliniken AG News
- 11 days ago - M1 Kliniken AG Annual report: H2 2025 - Filings
- 11 days ago - M1 Kliniken AG Earnings release: H2 2025 - Filings
- 19 days ago - EQS-Adhoc: M1 Kliniken AG: Supervisory Board adopts annual financial statements 2025. Dividend proposal of EUR 1.20 per share - Wallstreet:Online
- 6 months ago - EQS-News: Expansion of the Management Board of M1 Kliniken AG - Wallstreet:Online
- 6 months ago - M1 Kliniken AG: 11% EBIT Surge, EPS Hits €0.86 - Wallstreet:Online
- 6 months ago - EQS-News: M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86. - Wallstreet:Online
- 6 months ago - M1 Kliniken AG Earnings release: Q3 2025 - Filings
- 8 months ago - EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group - Wallstreet:Online